RECRUITINGINTERVENTIONAL

Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease

About This Trial

The goal of this clinical trial is to learn whether home-based transcranial direct current stimulation (tDCS) is safe and practical for people aged 40 to 70 years with Parkinson's Disease. The study aims to find out if participants can use the tDCS device at home without serious side effects and whether it is easy for them to use on their own. Participants will first attend an in-person visit to learn how to use the tDCS device. They will then use the device at home once a day for 20 minutes over seven consecutive days. Video calls on days 2 and 3 will provide support and supervision. After each session, participants will complete brief online questionnaires about any side effects and how easy the device was to use. The study will also check if using tDCS at home improves motor symptoms in Parkinson's Disease by using a standard movement assessment.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients with the diagnosis of Parkinson's disease, aged between 40 and 70, who provide verbal and written willing to sign a consent form will be included. Patients should have access to a computer system for video calls and completing the questionnaires, and they must be able to use it. Who Should NOT Join This Trial: - Psychiatric symptoms such as moderate or severe depression - Cranial metal implants - Cardiac pacemaker - Epilepsy, stroke - Substance abuse - Inability to adjust the neoprene cap with the electrodes independently due to movement disturbances Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: * Patients with the diagnosis of Parkinson's disease, aged between 40 and 70, who provide verbal and written informed consent will be included. Patients should have access to a computer system for video calls and completing the questionnaires, and they must be able to use it. Exclusion Criteria: * Psychiatric symptoms such as moderate or severe depression * Cranial metal implants * Cardiac pacemaker * Epilepsy, stroke * Substance abuse * Inability to adjust the neoprene cap with the electrodes independently due to movement disturbances

Treatments Being Tested

DEVICE

tDCS

The intervention involves a home-based, self-administered application of network-targeted, multifocal transcranial direct current stimulation (tDCS) using the Neuroelectrics® StarStim Home-tES device. Participants will apply the tDCS for 20 minutes each day over seven consecutive days. The device is specifically programmed to target a brain network associated with motor symptom improvement in Parkinson's Disease, based on recent research identifying this network through deep brain stimulation studies.

Locations (1)

Center for Brain Circuit Therapeutics, Department of Neurology, Brigham & Women's Hospital

Boston, Massachusetts, United States